-

Dante Labs Offers 200 Free Human Whole Genome Sequencing Tests to Scientists for Global Research Projects on Coronavirus

L’AQUILA, Italy--(BUSINESS WIRE)--Dante Labs, a world leader in whole genome sequencing and data analysis, today announced the first part of its program to support global scientific research on Coronavirus, offering free genome sequencing services to research projects on Coronavirus.

The goal is to help understand how different genes determine our reaction to Coronavirus: who gets sick, who doesn’t, how the human body reacts to the virus and why. Combining genomic, molecular and virology data can lead to identify variants and then develop molecules that will help the body’s defense against Coronavirus.

Dante Labs will provide free whole genome sequencing services to research projects related to Coronavirus, to sequence individuals affected with the virus. In the first part of the project, the company will provide free whole genome sequencing for 200 individuals.

“This is only the beginning of the program,” Dante Labs CEO Andrea Riposati declared, “We are receiving support from some selected partners to expand the program to thousands of samples worldwide. At Dante Labs, we thought hard about how we could help society in this emergency. We chose to donate to science what we do best: the whole genome. Genomic studies on Coronavirus can help us defend ourselves against this threat as well as the next one.”

Researchers from any country can present their project on the Dante Labs website or by emailing business@dantelabs.com.

About Dante Labs

Dante Labs is a world leader in whole genome sequencing tests and data analysis. To-date, people in 97 countries have personally experienced the power of the whole genome thanks to Dante Labs. The company global whole genome sequencing platform enables individuals to access actionable insights on their predispositions, reaction to medications and personalised medicine everywhere in the world. To learn more, please visit www.dantelabs.com and follow @DanteLabs.

Contacts

Francesca Tarquinio
business@dantelabs.com
+39-389-596-1301

Dante Labs

Details
Headquarters: New York, USA
CEO: Andrea Riposati
Employees: 42
Organization: PRI

Release Summary
Dante Labs provides free human whole genome sequencing services to global research projects on Coronavirus.
Release Versions

Contacts

Francesca Tarquinio
business@dantelabs.com
+39-389-596-1301

Social Media Profiles
More News From Dante Labs

Trieste, L'Aquila, Rome: the Italian genomics triangle assembles the new diploid RPE-1 genome, the missing piece for CRISPR, immediately published in California and on Nature magazine – with Dante Labs, Area Science Park, and La Sapienza University

ROME--(BUSINESS WIRE)--A few weeks ago, the USCS Genome Browser at the University of California, Santa Cruz, the bible of reference genomics, published a new and very important reference genome, Diploid RPE-1, key to the study of centromeres, thanks to the work of the Area Science Park in Trieste, the Giunta Lab at Sapienza University, Dante Labs, and the University of L'Aquila. These innovative Italian institutions have formed an international alliance with Rockefeller University in New York a...

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, Rockefeller University, Giunta Lab, Sapienza University, University of Tennessee, Trieste Area Science Park and University of L’Aquila published the successful assembly of a near-complete human diploid reference genome for one of the world’s most widely used cell lines. This breakthrough provides a reference-quality blueprint of the RPE-1 cell line, a workhorse in laboratories around the globe. Dante Omics leveraged its expertise with the Dante Labs ge...

Dante Omics AI Ushers Genomics Into the AI Age With GPU-Accelerated Proprietary Multiomics Platform

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, a pioneering force in computational genomics, today announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented speed and accuracy in genomic analysis, marking a transformative leap forward in bringing genomics fully into the artificial intelligence age. Revolutionary GPU-Accelerated Genomics Pipel...
Back to Newsroom